Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer

Gastric Cancer

Volumn 14, Issue 1, 2011, Pages 4-12

  Ubukata, Hideyuki ^a   Nagata, Hiroyuki ^a   Tabuchi, Takanobu ^a   Konishi, Satoru ^a   Kasuga, Teruhiko ^a   Tabuchi, Takafumi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Duodenal ulcer; Gastric acid; Gastric cancer; Helicobacter pylori; Polymorphism

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BLOOD GROUP ANTIGEN; CAGA PROTEIN; CARCINOGEN; CIMETIDINE; CYCLOOXYGENASE 2; GASTRIN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; NITROSO DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RETINOL; TUMOR NECROSIS FACTOR ALPHA; VACUOLATING TOXIN; VASCULOTROPIN;

ACHLORHYDRIA; AGE DISTRIBUTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER INHIBITION; CANCER RISK; CANCER SURVIVAL; CELL DAMAGE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DIAGNOSTIC ERROR; DIET; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DUODENUM ULCER; FOOD INTAKE; FRUIT; HELICOBACTER INFECTION; HUMAN; HYPERCHLORHYDRIA; INFECTION PREVENTION; NONHUMAN; ORGANISMAL INTERACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; RISK REDUCTION; SALT INTAKE; SEX DIFFERENCE; SMOKING; STOMACH ACID SECRETION; STOMACH EPITHELIUM; STOMACH JUICE; STOMACH ULCER; VAGOTOMY; VEGETABLE;

ANIMALS; ANTACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; DUODENAL ULCER; FOOD HABITS; HELICOBACTER PYLORI; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953026901     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-011-0005-9     Document Type: Article

References (99)

1. NR Hussein 2010 The association of dupA and Helicobacter pylori-related gastroduodenal diseases Eur J Clin Microbiol Infect Dis 29 817 821 20419465 10.1007/s10096-010-0933-z 1:STN:280:DC%2BC3crivFKqug%3D%3D
2. Infection with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer; 1994. p. 177-241.
3. A Labigne H de Reuse 1996 Determinants of Helicobacter pylori pathogenicity Infect Agents Dis 5 191 202 8884364 1:CAS:528:DyaK28Xmt1SjsL4%3D (Pubitemid 26317982)
4. DY Graham 1997 Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model Gastroenterology 113 1983 1991 9394739 10.1016/S0016-5085(97)70019-2 1:STN:280:DyaK1c%2Fls1Ohsw%3D%3D (Pubitemid 27512158)
5. GN Stemmermann C Fenoglio-Preiser 2002 Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precursors to a preventable cancer Pathology 34 494 503 12555987 1:CAS:528: DC%2BD3sXit1Ghsg%3D%3D (Pubitemid 36026724)
6. N Uemura S Okamoto S Yamamoto N Matsumura S Yamaguchi M Yamakido, et al. 2001 Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 784 789 11556297 10.1056/NEJMoa001999 1:STN:280:DC%2BD3MrgslCqtA%3D%3D
7. A Fischer OT Clagett JR McDonald 1947 Coexistent duodenal ulcer and gastric malignancy Surgery 21 168 174 20284783 1:STN:280:DyaH2s%2Fks1aqtQ%3D%3D
8. M Miwa I Senoue K Kikuchi H Watanabe T Nomiyama S Suzuki, et al. 1981 The coexistence of gastric cancer and duodenal ulcers Tokai J Exp Clin Med 6 203 205 6272449 1:STN:280:DyaL38%2Fmt1Kmsw%3D%3D (Pubitemid 11001495)
9. S Take M Mizuno K Ishiki Y Nagahara T Yoshida K Yokota, et al. 2005 The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease Am J Gastroenterol 100 1037 1042 15842576 10.1111/j.1572-0241.2005.41384.x (Pubitemid 40769039)
10. T Kamada J Hata K Sugiu H Kusunoki M Ito S Tanaka, et al. 2005 Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan Aliment Pharmacol Ther 21 1121 1126 15854174 10.1111/j.1365-2036.2005.02459.x 1:STN:280:DC%2BD2M3hvV2mug%3D%3D (Pubitemid 40646538)
11. L Fuccio RM Zagari ME Minardi F Bazzoli 2007 Systematic review: Helicobacter pylori for the prevention of gastric cancer Aliment Pharmacol Ther 25 133 141 17229238 10.1111/j.1365-2036.2006.03183.x 1:STN:280: DC%2BD2s%2Fjt1SntQ%3D%3D (Pubitemid 46046370)
12. MF Go DY Graham 1994 How does Helicobacter pylori cause duodenal ulcer disease: the bug, the host, or both? J Gastroenterol Hepatol 9 Suppl 1 S8 S10 7881025 10.1111/j.1440-1746.1994.tb01294.x
13. JC Atherton 1997 The clinical relevance of strain types of Helicobacter pylori Gut 40 701 703 9245920 10.1136/gut.40.6.701 1:STN:280: DyaK2szovVKrtQ%3D%3D (Pubitemid 27305459)
14. JC Atherton RM Peek Jr KT Tham TL Cover MJ Blaser 1997 Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori Gastroenterology 112 92 99 8978347 10.1016/S0016- 5085(97)70223-3 1:STN:280:DyaK2s7jt12rug%3D%3D (Pubitemid 27008990)
15. S Censini C Lange Z Xiang JE Crabtree P Ghiara M Borodovsky, et al. 1996 cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors Proc Natl Acad Sci USA 93 14648 14653 8962108 10.1073/pnas.93.25.14648 1:CAS:528:DyaK28XnsVOjsrg%3D (Pubitemid 26419022)
16. C Prinz M Schoniger R Rad I Becker E Keiditsch S Wagenpfeil, et al. 2001 Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesion during chronic gastric inflammation Cancer Res 61 1903 1909 11280745 1:CAS:528:DC%2BD3MXit1Ogsr4%3D (Pubitemid 32692006)
17. SD Li D Kersulyte IJ Lindley B Neelam DE Berg JE Crabtree 1999 Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells Infect Immun 67 3893 3899 10417153 1:CAS:528: DyaK1MXkvVKls7c%3D (Pubitemid 29357007)
18. D Marrelli C Pedrazzani A Berardi G Corso A Neri L Garosi, et al. 2009 Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer Cancer 115 2071 2080 19280589 10.1002/cncr.24253 1:CAS:528:DC%2BD1MXlvFOiu7o%3D
19. S Odenbreit J Puls B Sedlmaier E Gerland W Fischer R Haas 2000 Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion Science 287 1497 1500 10688800 10.1126/science.287.5457.1497 1:CAS:528:DC%2BD3cXhsV2qtL0%3D (Pubitemid 30127145)
20. JQ Huang GF Zheng K Sumanac EJ Irvine RH Hunt 2003 Meta-analysis of the relationship between cagA seropositivity and gastric cancer Gastroenterology 125 1636 1644 14724815 10.1053/j.gastro.2003.08.033 (Pubitemid 37500427)
21. EJ Kuipers GI Perez-Perez SG Meuwissen MJ Blaser 1995 Helicobacter pylori and atrophic gastritis: importance of the cagA status J Natl Cancer Inst 87 1777 1780 7473834 10.1093/jnci/87.23.1777 1:STN:280:DyaK28%2FnslSkuw%3D%3D
22. M Hatakeyama 2004 Oncogenic mechanisms of the Helicobacter pylori CagA protein Nat Rev Cancer 4 688 694 15343275 10.1038/nrc1433 1:CAS:528: DC%2BD2cXntFCmsbc%3D (Pubitemid 39215067)
23. Y Yamaoka T Kodama K Kashima DY Graham AR Sepulveda 1998 Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from different H. pylori associated diseases J Clin Microbiol 36 2258 2263 9666002 1:CAS:528:DyaK1cXkvVWisrg%3D (Pubitemid 28324077)
24. AM Nomura GI Perez-Perez J Lee G Stemmermann MJ Blaser 2002 Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease Am J Epidemiol 155 1054 1059 12034584 10.1093/aje/155.11.1054 (Pubitemid 34587489)
25. H Lu PY Hsu DY Graham Y Yamaoka 2005 Duodenal ulcer promoting gene of Helicobacter pylori Gastroenterology 128 833 848 15825067 10.1053/j.gastro.2005. 01.009 1:CAS:528:DC%2BD2MXjvV2qtrg%3D (Pubitemid 40523536)
26. RH Argent A Burette VY Miendje Deyi JC Atherton 2007 The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America Clin Infect Dis 45 1204 1206 17918084 10.1086/522177 1:CAS:528:DC%2BD2sXht1ykt7jI (Pubitemid 47580321)
27. LT Nguyen T Uchida Y Tsukamoto A Kuroda T Okimoto M Kodama, et al. 2010 Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population Clin Microbiol Infect 16 8 1264 1269 19832706 10.1111/j.1469-0691.2009.03081.x 1:CAS:528:DC%2BC3cXhtFCgtbzF
28. HS Arachchi V Kalra B Lal V Bhatia CS Baba S Chakravarthy, et al. 2007 Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population Helicobacter 12 591 597 18001398 10.1111/j.1523-5378.2007.00557.x 1:CAS:528:DC%2BD1cXjs1SisA%3D%3D (Pubitemid 350132070)
29. SW Jung M Sugimoto DY Graham Y Yamaoka 2009 homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer J Clin Microbiol 47 3241 3245 19710266 10.1128/JCM.00293-09 1:CAS:528: DC%2BD1MXhsVeru77J
30. Camels S, Bereziat JC, Oshima H, Bartsch H. Bacterial formation of N-nitroso compounds in rats after omeprazole-induced achlorhydria. In: O'Neill IK, Chen J, Bartsch H, editors. Relevance to human cancer of N-nitroso compounds, tobacco smoke and mycotoxins (IARC scientific publication no. 105). Lyon: International Agency for Research on Cancer; 1991. p. 187-91.
31. S Sanduleanu D Jonkers A De Bruïne W Hameeteman RW Stockbrügger 2001 Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis Aliment Pharmacol Ther 15 1163 1175 11472319 10.1046/j.1365-2036.2001.01029.x 1:STN:280: DC%2BD38%2FislSntA%3D%3D (Pubitemid 32675450)
32. R Lamberts W Creutzfeldt HG Strüber G Brunner E Solcia 1993 Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis Gastroenterology 104 1356 1370 8482449 1:STN:280:DyaK3s3ks1WitQ%3D%3D (Pubitemid 23235408)
33. EC Klinkenberg-Knol F Nelis J Dent P Snel B Mitchell P Prichard, et al. 2000 Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa Gastroenterology 118 661 669 10734017 10.1016/S0016-5085(00)70135-1 1:CAS:528:DC%2BD3cXis1ens74%3D (Pubitemid 30171615)
34. N Havu 1986 Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion Digestion 35 Suppl 1 42 55 3792671 10.1159/000199381 (Pubitemid 17197933)
35. D Gillen KE McColl 2001 Problem associated with the clinical use of proton pump inhibitors Pharmacol Toxicol 89 281 286 11903952 10.1034/j.1600-0773.2001.d01-161.x 1:CAS:528:DC%2BD38XovFCg (Pubitemid 34008377)
36. EJ Kuipers 2006 Proton pump inhibitors and gastric neoplasia Gut 55 1217 1221 16905689 10.1136/gut.2005.090514 1:CAS:528:DC%2BD28XhtVehurjL (Pubitemid 44277346)
37. EJ Kuipers P Sipponen 2006 Helicobacter pylori eradication for the prevention of gastric cancer Helicobacter 11 Suppl 1 52 57 16925613 10.1111/j.1478-405X.2006.00425.x
38. G Lundegårdh A Ekbom JK McLaughlin O Nyrén 1994 Gastric cancer risk after vagotomy Gut 35 946 949 8063222 10.1136/gut.35.7.946 (Pubitemid 24202725)
39. H Møller A Nissen J Mosbech 1992 Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users Gut 33 1166 1169 1358764 10.1136/gut.33.9.1166
40. JB Elder PC Ganguli IE Gillespie 1979 Cimetidine and gastric cancer Lancet 1 1005 1006 86721 10.1016/S0140-6736(79)92757-0 1:CAS:528: DyaE1MXlvVKktLo%3D (Pubitemid 9183428)
41. TJ Muscroft DJ Youngs DW Burdon Keighley 1981 Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet Lancet I 408 410 10.1016/S0140-6736(81)91791-8 (Pubitemid 11188932)
42. CY Lin DJ Bai HY Yuan K Wang GL Yang MB Hu, et al. 2004 Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial World J Gastroenterol 10 136 142 14695785 1:CAS:528:DC%2BD2cXhtVelsrY%3D (Pubitemid 38071994)
43. AD Milito S Fais 2005 Proton pump inhibitor may reduce tumour resistance Scand J Gastroenterol 6 1049 1054 (Pubitemid 40959470)
44. RO Dillman G Soori C DePriest SK Nayak LD Beutel C de Leon, et al. 2003 Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the Cancer Biotherapy Research Group Cancer Biother Radiopharm 18 727 733 14629821 10.1089/108497803770418274 1:CAS:528:DC%2BD3sXptFaiu70%3D (Pubitemid 37377308)
45. CG Jiang FR Liu JB Li HM Xu 2010 Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo Oncol Rep 23 693 700 20127008 10.3892/or-00000786 1:CAS:528:DC%2BC3cXjtlGrtr0%3D
46. MJS Langman JA Dunn JL Whiting A Burton MT Hallissey JWL Fielding, et al. 1999 Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer Br J Cancer 81 1356 1362 10604733 10.1038/sj.bjc.6690457 1:CAS:528:DC%2BD3cXls1KksQ%3D%3D
47. G Gridley JK McLaughlin A Ekbom L Klareskog HO Adami DG Hacker, et al. 1993 Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 307 311 8426374 10.1093/jnci/85.4.307 1:STN:280:DyaK3s7kvVehsQ%3D%3D (Pubitemid 23068804)
48. MJ Thun MM Namboodiri EE Calle WD Flanders CW Health Jr 1993 Aspirin use and risk of fatal cancer Cancer Res 53 1322 1327 8443812 1:CAS:528: DyaK3sXktl2qtLY%3D (Pubitemid 23097110)
49. WH Wang JQ Huang GF Zheng SK Lam J Karlberg BC Wong 2003 Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis J Natl Cancer Inst 95 1784 1791 14652240 1:CAS:528: DC%2BD3sXpvVelsbk%3D (Pubitemid 38008901)
50. Shirin H, Moss SF, Stark B, Weinstein IB, Holt PR, Sordillo EM. Inhibition of Helicobacter pylori growth by sulindac. Gastroenterology. 2000;119:A4931 (abstract).
51. M Takahashi Y Katayama H Takada H Kuwayama A Terano 2000 The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts Aliment Pharmacol Ther 14 Suppl 1 44 49 10807402 10.1046/j.1365-2036.2000.014s1044.x 1:CAS:528:DC%2BD3cXjtl2js78%3D (Pubitemid 30199104)
52. N Hudson M Balsitis F Filipowicz CJ Hawkey 1993 Effect of Helicobacter pylori colonization on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs Gut 34 748 751 8314505 10.1136/gut.34.6.748 1:STN:280:DyaK3szgtVeqtg%3D%3D (Pubitemid 23185097)
53. MM Wolfe DR Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Engl J Med 340 1888 1899 10369853 10.1056/NEJM199906173402407 1:CAS:528:DyaK1MXktFKrtbs%3D (Pubitemid 29272670)
54. LA Garcia Rodriguez J Lagergren M Lindblad 2006 Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK Gut 55 1538 1544 16785284 10.1136/gut.2005.086579 1:STN:280: DC%2BD28nhtlCitA%3D%3D (Pubitemid 44629198)
55. KE McColl 2006 Acid inhibitory medication and risk of gastric and oesophageal cancer Gut 55 1532 1533 17047103 10.1136/gut.2006.103283 1:STN:280:DC%2BD28nhtlCiuw%3D%3D (Pubitemid 44629195)
56. P Correa C Cuello LF Fajardo W Haenszel O Bolaños B de Ramirez 1983 Diet and gastric cancer: nutrition survey in a high-risk area Natl Cancer Inst 70 673 678 1:STN:280:DyaL3s7msFSksg%3D%3D (Pubitemid 13137148)
57. J Parsonnet GD Friedman DP Vandersteen Y Chang JH Vogelman N Orentreich, et al. 1991 Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 325 1127 1131 1891020 10.1056/NEJM199110173251603 1:STN:280:DyaK3Mzmslahuw%3D%3D
58. P Correa MB Piazuelo MC Camargo 2004 The future of gastric cancer prevention Gastric Cancer 7 9 16 15052434 10.1007/s10120-003-0265-0 (Pubitemid 38470689)
59. M Kobayashi Y Tsubono S Sasazuki S Sasaki S Tsugane 2002 Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I Int J Cancer 102 39 44 12353232 10.1002/ijc.10659 1:CAS:528: DC%2BD38XnvFCru78%3D
60. TS Chen YC Lee FY Li FY Chang 2005 Smoking and hyperpepsinogenemia are associated with increased risk for duodenal ulcer in Helicobacter pylori-infected patients J Clin Gastroenterol 39 699 703 16082280 10.1097/01.mcg.0000173854.55172.ee (Pubitemid 41177090)
61. R Sierra C Une V Ramirez MI Gonzalez JA Ramirez A de Mascarel, et al. 2006 Association of serum pepsinogen with atrophic body gastritis in Costa Rica Clin Exp Med 6 72 79 16820994 10.1007/s10238-006-0098-3 1:CAS:528: DC%2BD28XmsFOnurw%3D
62. Faber K. Gastritis and its consequences. London: Oxford University Press; 1935.
63. A Nyfeldt B Vimtrup 1932 Gastritis acuta bei diphtheria faucium Acta Med Scand 78 447 483 10.1111/j.0954-6820.1932.tb10767.x
64. Schoen AM. Acute gastritis. In: Bockus HL, editor. Gastroenterology. 2nd ed. Philadelphia: Saunders; 1963. p. 351-67.
65. M Suzuki S Miura M Suematsu D Fukumura I Kurose H Suzuki, et al. 1992 Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury Am J Physiol 263 G719 G725 1443147 1:CAS:528:DyaK3sXpvFaqsw%3D%3D
66. M Murakami K Asagoe H Dekigai S Kusaka H Saita T Kita 1995 Products of neutrophil metabolism increase ammonia-induced gastric mucosal damage Dig Dis Sci 40 268 273 7851188 10.1007/BF02065408 1:CAS:528:DyaK2MXltlGrtLo%3D
67. M Takashima T Furuta H Hanai H Sugimura E Kaneko 2001 Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils Gut 48 765 773 11358893 10.1136/gut.48.6.765 1:STN:280:DC%2BD3M3msl2jsA%3D%3D (Pubitemid 32476976)
68. JV Esplugues MA Martinez-Cuesta MD Barrachina S Calatayud BJ Whittle 1994 Involvement of endogenous nitric oxide in the inhibition by endotoxin and interleukin-1 beta of gastric acid secretion J Gastroenterol Hepatol 9 Suppl 1 S45 S49 7881019 10.1111/j.1440-1746.1994.tb01301.x
69. S Kondo Y Shinomura S Kanayama S Kawabata Y Miyazaki I Imamura, et al. 1993 Interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion Br J Pharmacol 108 9 10
70. EM El-Omar CS Rabkin MD Gammon TL Vaughan HA Risch JB Schoenberg, et al. 2003 Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms Gastroenterology 124 1193 1201 12730860 10.1016/S0016-5085(03)00157-4 1:CAS:528:DC%2BD3sXktVSktrw%3D (Pubitemid 36531795)
71. T Furuta EM El-Omar F Xiao N Shirai M Takashima H Sugimura 2002 Interleukin 1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan Gastroenterology 123 92 105 12105837 10.1053/gast.2002.34156 1:CAS:528:DC%2BD38Xmt1aiu7o%3D (Pubitemid 34747529)
72. C Figueiredo JC Machado P Pharoah R Seruca S Sousa R Carvalho, et al. 2002 Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high risk individuals for gastric carcinoma J Natl Cancer Inst 94 1680 1687 12441323 1:CAS:528:DC%2BD38Xpslequrw%3D (Pubitemid 35446836)
73. MC Camargo R Mera P Correa RM Peek Jr ET Fontham KJ Goodman, et al. 2006 Interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis Cancer Epidemiol Biomarkers Prev 15 1674 1687 16985030 10.1158/1055-9965.EPI-06-0189 1:CAS:528:DC%2BD28Xps1ynt7o%3D (Pubitemid 44497104)
74. CF Zambon D Basso F Navaglia C Belluco A Falda P Fogar, et al. 2005 Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome Cytokine 29 141 152 15652446 10.1016/j.cyto.2004.10.013 1:CAS:528:DC%2BD2MXisFKrtA%3D%3D (Pubitemid 40126232)
75. EM El-Omar M Carrington WH Chow KE McColl JH Bream HA Young, et al. 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398 402 10746728 10.1038/35006081 1:CAS:528:DC%2BD3cXitlyltb4%3D (Pubitemid 30164342)
76. S Kato M Onda S Yamada N Matsuda A Tokunaga N Matsukura 2001 Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese J Gastroenterol 36 696 699 11686480 10.1007/s005350170033 1:CAS:528:DC%2BD3MXot1WmsrY%3D (Pubitemid 33040943)
77. SG Lee B Kim W Choi I Lee J Choi K Song, et al. 2003 Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B-31 C/+ and IL-1RN2/2) and gastric cancer/duodenal ulcer in Korean population Cytokine 21 167 171 12788304 10.1016/S1043-4666(03)00032-2 1:CAS:528:DC%2BD3sXkt1Ghtbg%3D (Pubitemid 36677434)
78. LI Gatti RR Burbano PP de Assumpção A Smith Mde SL Payão 2004 Interleukin-1 beta polymorphisms, Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma Clin Exp Med 4 93 98 15672946 10.1007/s10238-004-0043-2 (Pubitemid 39516983)
79. F Kamangar CC Abnet AA Hutchinson CJ Newschaffer K Helzlsouer YY Shugart, et al. 2006 Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland) Cancer Causes Control 17 117 125 16411061 10.1007/s10552-005- 0439-7 (Pubitemid 43084810)
80. YW Chang HC Oh JY Jang Y Hwangbo JW Lee J Lee, et al. 2008 IL-1B and IL-8, matrix metalloproteinases 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes Scand J Gastroenterol 43 1184 1193 18609140 10.1080/00365520802130209 1:CAS:528:DC%2BD1cXhtFCiu77O
81. O Partida-Rodríguez J Torres L Flores-Luna M Camorlonga M Nieves-Ramírez E Lazcano, et al. 2010 Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer Int J Cancer 126 1861 1868 19626584
82. MK Jones H Kawanaka D Baatar IL Szabó K Tsugawa R Pai, et al. 2001 Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angioprotein-1 Gastroenterology 121 1040 1047 11677194 10.1053/gast.2001.29308 1:CAS:528:DC%2BD3MXpt1SrsLo%3D (Pubitemid 33022082)
83. N Suzuki S Takahashi S Okabe 1998 Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcer in rats J Physiol Pharmacol 49 515 527 10069693 1:CAS:528:DyaK1MXmvVOnsA%3D%3D (Pubitemid 29024370)
84. Y Takahashi KR Clearly M Mai Y Kitadai CD Bucana LM Ellis 1996 Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer Clin Cancer Res 2 1679 1684 9816116 1:STN:280:DyaK1M%2FjsFWqtA%3D%3D (Pubitemid 26356351)
85. K Maeda SM Kang N Onoda M Ogawa Y Kato T Sawada, et al. 1999 Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma Cancer 86 566 571 10440683 10.1002/(SICI)1097-0142(19990815)86:4<566::AID-CNCR4>3.0. CO;2-1 1:STN:280:DyaK1MzmvFOntA%3D%3D (Pubitemid 29379401)
86. CW Feng LD Wang LH Jiao B Liu S Zheng XJ Xie 2000 Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features BMC Cancer 29 2 8
87. T Tahara T Shibata M Nakamura H Yamashita D Yoshioka I Hirata, et al. 2009 Effect of polymorphisms in the 3′ untranslated region (3′-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan Mol Carcinog 48 1030 1037 19496079 10.1002/mc.20554 1:CAS:528:DC%2BD1MXhtleqtbjM
88. S Takatsu H Tsuchiya A Kitamura S Yoshida M Ito Y Sakurai, et al. 1984 Detection of early gastric cancer by panendoscopy Jpn J Clin Oncol 14 243 252
89. O Hosokawa Y Kaizaki T Nakaya T Hinoshita K Watanabe K Douden, et al. 2000 Retrospective study of endoscopic findings: 250 cases of gastric cancer Dig Endosc 12 136 140 10.1046/j.1443-1661.2000.00026.x (Pubitemid 30315986)
90. K Mabe M Takahashi H Oizumi H Tsukuma A Shibata K Fukase, et al. 2009 Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World J Gastroenterol 14 4290 4297 10.3748/wjg.15.4290
91. P Correa 1992 Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 52 6735 6740 1458460 1:CAS:528: DyaK3sXjs1Orsw%3D%3D (Pubitemid 23006271)
92. S Khulusi S Badve P Patel R Lloyd JM Marrero C Finlayson, et al. 1996 Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration Gastroenterology 110 452 458 8566592 10.1053/gast.1996.v110.pm8566592 1:STN:280:DyaK287ls1SntQ%3D%3D (Pubitemid 26043878)
93. P Sipponen P Ranta T Helske I Kaariainen T Maki A Linnala, et al. 2002 Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study Scand J Gastroenterol 37 785 791 12190091 1:CAS:528:DC%2BD38XmvVSkt7s%3D (Pubitemid 34836814)
94. MS Wu CJ Chen JT Lin 2005 Host-environmental interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer Cancer Epidemiol Biomarkers Prev 14 1878 1882 16103430 10.1158/1055-9965.EPI-04-0792 (Pubitemid 41161193)
95. IR Hwang T Kodama S Kikuchi K Sakai LE Peterson DY Graham, et al. 2002 Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection Gastroenterology 123 1793 1803 12454835 10.1053/gast.2002.37043 1:CAS:528:DC%2BD38Xps1yktb4%3D (Pubitemid 35408303)
96. FP Brooks 1985 The pathophysiology of peptic ulcer disease Dig Dis Sci 30 Suppl 11 15S 29S 4053922 10.1007/BF01309381 1:STN:280:DyaL28%2FivFyguw%3D%3D (Pubitemid 16180530)
97. BN Ames LS Gold 1990 Too many rodent carcinogens: mitogenesis increases mutagenesis Science 249 970 971 2136249 10.1126/science.2136249 1:STN:280:DyaK3czntFejtg%3D%3D
98. T Kubo T Imai 1971 Intestinal metaplasia of gastric mucosa in autopsy materials in Hiroshima and Yamaguchi districts Gann 62 49 53 5553380 1:STN:280:DyaE3M7mtlKjsg%3D%3D
99. E Solcia R Fiocca O Luinetti L Villani L Padovan D Calistri, et al. 1996 Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement Am J Surg Pathol 20 Suppl 1 S8 S22 8694148